# US 2002/0055722 A1 · Subcutaneous injection set tubing with solvent bonding

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0055722 A1
- Document ID: US20020055722A1
- Status: Published application
- Kind: A1
- Application number: 09/944,229
- Filed: 2001-08-30
- Published: 2002-05-09
- Earliest claimed: 2000-11-06
- Assignees: Sterling Medivations, Inc.
- Inventors: Joel Sterling Douglas; Robert Louis Hueo; Hiroshi Nomvra
- Web page: https://patentgrep.com/patent/US20020055722A1

## CPC

- C08J 5/122: {using low molecular chemically inert solvents, swelling or softening agents}
- A61M 39/12: for joining a flexible tube to a rigid attachment
- B29C 65/48: using adhesives {, i.e. using supplementary joining material; solvent bonding}
- B29C 66/112: {Single lapped joints}
- B29C 66/1122: {Single lap to lap joints, i.e. overlap joints (B29C66/45, B29C66/472, B29C66/52272 take precedence)}
- B29C 66/1222: {comprising at least a lapped joint-segment}
- B29C 66/1224: {comprising at least a butt joint-segment}
- B29C 66/131: {Single flanged joints, i.e. one of the parts to be joined being rigid and flanged in the joint area}
- B29C 66/5344: {said single elements being substantially annular, i.e. of finite length, e.g. joining flanges to tube ends (B29C66/5346 takes precedence)}
- B29C 66/612: {Making circumferential joints}
- B29C 66/71: {characterised by the composition of the plastics material of the parts to be joined (welding bar compositions B29C65/125)}
- A61M 5/158: Needles {for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body}
- A61M 25/0014: {Connecting a tube to a hub}
- B29C 59/142: {of profiled articles, e.g. hollow or tubular articles}
- B29C 65/484: {Moisture curing adhesives}
- B29K 2023/06: {PE, i.e. polyethylene}
- B29K 2023/12: {PP, i.e. polypropylene}
- B29K 2027/06: PVC, i.e. polyvinylchloride
- B29K 2069/00: Use of PC, i.e. polycarbonates {or derivatives thereof}, as moulding material
- B29L 2031/7544: {Injection needles, syringes}
- C08J 2323/06: Polyethene
- C08J 2327/18: Homopolymers or copolymers of tetrafluoroethylene
- Y10T 428/139: Open-ended, self-supporting conduit, cylinder, or tube-type article
- Y10T 428/1393: Multilayer [continuous layer]
- Y10T 428/265: 1 mil or less
- Y10T 428/31544: Addition polymer is perhalogenated
- Y10T 428/3192: Next to vinyl or vinylidene chloride polymer
- Y10T 428/31928: Ester, halide or nitrile of addition polymer
- Y10T 428/31935: Ester, halide or nitrile of addition polymer
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The infusion set comprises of a connecting tube of polyethylene which is treated to form a wetable surface or treated with a primer and then bonded to a PVC hub by using solvent adhesive to solvent bond the low density polyethylene tubing or Teflon tubing to a PVC hub. The surface treatment methods include a methane plasma surface that is applied to tubing in a continuous manner and alternatively a primer that is applied locally and dried prior to applying the adhesive. Both techniques form a strong and resilient bond for the infusion needle and tube when assembled to the PVC hubs.

## Claims

### Claim 1

A subcutaneous injection set comprising:
a hub, a tube connected to the hub and forming therewith a hub-tube joint, and a needle connected to the hub and forming therewith a needle-hub joint, the hub including a socket;
wherein said hub is molded of a plastic selected from the group consisting of PVC and PC;
wherein the tube is formed of a material selected from the group consisting of polyethylene and polypropylene and includes a polymer layer formed by plasma treating with methane and oxygen gas;
wherein solvent adhesive is applied to the needle-hub joint;
wherein solvent adhesive is applied to the hub-tube joint; and
wherein the tube has an outer diameter, and the hub has a minimum area to seal, a socket length, and a fully effective length which satisfy at least one of the relationships selected from the group consisting of
the minimum area to seal=outer diameter of the tube/6.25;
the minimum socket length=1 * outer diameter of the tube; and
the hub fully effective length is 1.6 * outer diameter of the tube.

### Claim 2 (depends on 1)

An infusion set as claimed in claim 1, wherein the tube is formed of polypropylene.

### Claim 3 (depends on 1)

An infusion set as claimed in claim 1, wherein the plasma polymer layer of methane has a thickness between about 10 Å and about 2000 Å.

### Claim 4

A subcutaneous injection set comprising:
a hub, a tube connected to the hub and forming therewith a hub-tube joint, and a needle connected to the hub and forming therewith a needle-hub joint, the hub including a socket;
wherein said hub is molded of a plastic selected from the group consisting of PVC and PC;
wherein the tube is formed of a material selected from the group consisting of polyethylene and polypropylene, and the tube includes a primer;
wherein solvent adhesive is applied to the needle-hub joint;
wherein solvent adhesive is applied to the hub-tube joint; and
wherein the tube has an outer diameter, and the hub has a minimum area to seal, a socket length, and a fully effective length which satisfy at least one of the relationships selected from the group consisting of
the minimum area to seal=outer diameter of the tube/16.67;
the minimum socket length=2 * outer diameter of the tube; and
the fully effective length is 2.6 * outer diameter of the tube.

### Claim 5 (depends on 4)

An infusion set as claimed in claim 4, where the tube is formed of polypropylene.

### Claim 6 (depends on 4)

An infusion set as claimed in claim 4, wherein the plasma polymer layer of methane has a thickness between about 10 Å0 and about 2000 Å.

### Claim 7

A subcutaneous injection set comprising:
a hub, a tube connected to the hub and forming therewith a hub-tube joint, and a needle connected to the hub and forming therewith a needle-hub joint, the hub including a socket;
wherein said hub is molded of a plastic selected from the group consisting of PVC and PC;
where the tube is formed of polytetrafluoroethylene includes a polymer layer formed by plasma treating with methane and oxygen gas;
wherein the tube has an outer diameter, the hub has a minimum socket length, the solvent adhesive is applied to the needle-hub joint, and the solvent adhesive satisfies at least one of the relationships selected from the group consisting of
the minimum area to seal=outer diameter of the tube/3.33; and
the minimum socket length=1.9 * outer diameter of the tube; and
the fully effective length is 2.8* outer diameter of the tube.

### Claim 8 (depends on 7)

An infusion set as claimed in claim 7, wherein the plasma polymer layer of methane has a thickness between about 10 Å and about 2000 Å.

### Claim 9

A solvent bondable joint comprising:
a LDPE part having a plasma deposited layer of methane and oxygen gas;
a solvent adhesive applied to the joint;
a solvent bondable piece in communication with the solvent adhesive; and
wherein the plasma polymer layer of methane is at least 10 Å thick but not greater than 2000 Å.

### Claim 10

A solvent bondable joint comprising:
a polytetrafluoroethylene part having a plasma deposited layer of methane and oxygen gas;
a solvent adhesive applied to the joint;
a solvent bondable piece in communication with the solvent adhesive; and
wherein the plasma polymer layer of methane is at least 10 Å thick but not greater than 2000 Å.

### Claim 11

A solvent bondable joint comprising:
a LDPE part having a plasma deposited layer of methane and oxygen gas;
a solvent adhesive applied to the joint;
a LDPE part having a plasma deposited layer of methane and oxygen gas in communication with the solvent adhesive; and
wherein the plasma polymer layer of methane is at least 10 Å thick but not greater than 2000 Å.

### Claim 12

A solvent bondable joint comprising:
a polytetrafluoroethylene part having a plasma deposited layer of methane and oxygen gas
a solvent adhesive applied to the joint;
a polytetrafluoroethylene part having a plasma deposited layer of methane and oxygen gas in communication with the solvent adhesive; and
wherein the plasma polymer layer of methane is at least 10 Å thick but not greater than 2000 Å.

### Claim 13

A solvent bondable joint comprising:
a LDPE part having a plasma deposited layer of methane and oxygen gas;
a solvent adhesive applied to the joint;
a polytetrafluoroethylene part having a plasma deposited layer of methane and oxygen gas in communication with the solvent adhesive; and
wherein the plasma polymer layer of methane is at least 10 Å thick but not greater than 2000 Å.
